Surgery for Crohn's Disease: Experience in the Department of General Surgery: A Retrospective Study of 60 Cases

A. Bachar

Visceral Surgery Department, University Hospital Center Ibn Rochd, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.

N. Fakhiri *

Visceral Surgery Department, University Hospital Center Ibn Rochd, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.

K. Falousse

Visceral Surgery Department, University Hospital Center Ibn Rochd, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.

T. El Abbassi

Visceral Surgery Department, University Hospital Center Ibn Rochd, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.

M. R. Lefriyekh

Visceral Surgery Department, University Hospital Center Ibn Rochd, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.

*Author to whom correspondence should be addressed.


Abstract

Crohn's disease (CD) consists of segmental digestive inflammation and transmural, Sometimes associated to anoperineal and extradigestive manifestations.

The clinical manifestations of our patients were varied ranging from simple pain Abdominal with diarrhea to occlusion or koenig's syndrome.

Paraclinical diagnosic was based on endoscopy and radiology performed on all our Patients.

The treatment of crohn disease is mainly medical, but surgery is still necessary in Case of complications or medical treatment resistance. Our work is a series of 60 patients, operated at the visceralSurgery department of the “CHU IBN ROCHD” Casablanca (Morocco). Over a period of 7 years, from 2015 to 2021. The purpose of which is to describe the surgical experience of the Department in the treatment of crohn's disease as well as its different indications.

The surgical indication was symptomatic stenosis in 38% of cases, and digestive Fistula in 36% of cases. The most used surgical approach was median laparotomy in 100% of patients.

The predominant surgical procedure was ileocecal resection performed in 58% of Patients In the absence of postoperative recurrence, surgery allows a significant Improvement in quality of life, however it will not cure the patient who will remain Exposed to a high risk of recurrence in the remaining bowel Mortality in our series was zero, morbidity was 16% of cases, represented by 6 Infections of the wall.

Keywords: Koenig's syndrome, crohn's disease, sténosis, fistula


How to Cite

Bachar, A., Fakhiri, N., Falousse, K., Abbassi, T. E., & Lefriyekh, M. R. (2022). Surgery for Crohn’s Disease: Experience in the Department of General Surgery: A Retrospective Study of 60 Cases. International Research Journal of Gastroenterology and Hepatology, 5(1), 164–169. Retrieved from https://journalirjgh.com/index.php/IRJGH/article/view/66

Downloads

Download data is not yet available.

References

Caroline Klotz, Marion Dhooge, Ammar Oudjit, Maximilien Barret, Frederic Beuvon, et al. Management of Crohn's disease. Med Press. 2015;44(4):411-417.

Bernstein Cn. World gastroenterology organization practice guidelines for the diagnosis and management of Ibd; 2010.

De Saussure P, Bouhnik Y. Adult Crohn's Disease. Emc. 2007;9-057-G-10

Dash E, Karoui M. Surgical treatment of crohn's disease: Principles of tactics and operative technique. Encycl Med Chir. Techniques. 2006;40- 667:10.

doi:10.1016/S0246-0424(06)39771-3

Crohn BB, Ginzburg. Regional Ileitis; A pathology and clinical entity. Journal of American Medical Association; Chicago. 1932;99:13:1329.

Crohn BB. Granulomatous disease of small and large bowel: A historical survey. Gastro-Enterology. 1967;767-772.

Brazier F. Remicade (Infliximab) in the treatment of crohn's disease” La Presse Médicale. September 16, 2000;29(26).

Colombel JF. Crohn's disease: Bacteria-mucosa interaction involved. Le Concours Médical Tome 124-10;2002.

Parodi André-Laurent. Crohn's disease and paratuberculosis of ruminants. The Practitioner's Review. 2002.52:1401-1404

Shutz G. Imaging of chronic small intestine stenosis. Emc. 2003;10:33-330.

Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657–63.

Cortot Antoine. Homogeneous groups of patients during Crohn's disease: reality or fantasy? Gastroenterol Clin and Biol. 1998;22:591-593.

Ford, Alexander C, Sandborn, William J, Khan, Khurram J, et al. Efficacy of biological therapies in inflammatory bowel disease: Systematic review and meta-analysis. The American Journal Of Gastroenterology. 2011;106(4):644-659.

De Saussure P, Bouhnik Y. Adult crohn’s disease. Emc. 2007;9-057-G-10.

Ali, Mr Fassi Fihri Mohamed. Risk factors for surgery for intestinal complications in patients with crohn's disease (About 218 Cases); 2016.

Elkessabi R. Surgical management of chronic inflammatory bowel disease. 2016.

Couturier M, Panis Y, Treton X, et al. Nod2 in ileal postoperative recurrence during crohn's disease surgery. 2016; 15(1):018-024.

Ephgrave K. Extra-intestinal manifestations of Crohn's disease. In: Surgical Clinics of North America. 2007;87:673-680.

Dignass A, Van Assche G, Lindsay JO. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis. 2010 Feb;4(1):28-62.

Dr Charles N. Inflammatory bowel disease: A global approach world gastroenterology organization global guidelines; 2009.

Manceau G, Panis Y. Surgical treatments for Crohn's disease. In: Post’U. France. Springer. 2011;125-131.